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Background: Acute respiratory infections represent a serious public health issue worldwide but virological
aetiologies of Influenza Like Illnesses (ILIs) remain largely unknown in developing countries. This study represents
the first attempt to characterise viral aetiologies of ILIs in Bolivia.
Methods: It was performed in Santa Cruz city from January 2010 to September 2012, based on 564 naso-pharyngeal
swabs collected in a National Reference Laboratory and real-time PCR techniques, viral cultures and phylogenetic
analyses.
Results: 50.2% of samples were positive for at least one virus with influenza viruses (Flu A: ~15%; Flu B: ~9%),
rhinoviruses (~8%), coronaviruses (~5%) and hRSV (~4%) being the most frequently identified. The pattern of viral
infections varied according to age groups. The elucidation rate was the highest (>60%) amongst patients under 10 yo
and the lowest (<40%) amongst patients ≥60 yo. Nearly 3% of samples showed dual viral infections. Epidemiological
peaks were associated with a predominant virus but generally included 30-50% of infections by different viruses.
Unexpectedly, the frequency of influenza in the 0–4 yo population was very low and a complete hRSV eclipse occurred
in 2011. Genetic analyses indicated that distinct evolutionary lineages of Flu A(H1N1)pdm2009, Flu A/H3N2 and Flu B
have co-circulated in Bolivia in the study period, originating from Central and North America, Europe, Asia and
Australia.
Conclusion: Our results emphasise the requirement for a reinforced epidemiological and genetic follow-up of influenza
and other ILIs in Bolivia to further inform the preparation of vaccines used in the region, guide vaccination campaigns
and improve the medical management of patients.
Keywords: Epidemiology, Influenza like illness, Bolivia, South America, Influenza A(H1N1)pdm2009, Influenza
phylogeny, Respiratory infectionsBackground
Acute respiratory tract infections (ARIs) represent a
leading cause of human acute illnesses worldwide and
an important contributing factor of childhood morbidity
and mortality, especially under the age of 5 [1-3]. Be-
sides the issue of bacterial pneumonia, which represents
a frequent cause of mortality in paediatric populations of
developing countries, there is an increasing interest in* Correspondence: jdelangue@gmail.com
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unless otherwise stated.the epidemiology and characterization of Influenza Like
Illnesses (ILIs), which are predominantly of viral aeti-
ology [4]. First, ILIs are responsible for a large number
of cases in all age groups (with a specifically high fre-
quency in children) and despite their frequent associ-
ation with a mild clinical presentation, their medical and
socio-economical impact is enormous [5]. Second, a pro-
portion of ILIs is associated with severe clinical evolution
[6]. In adults, viruses are the putative causative agents in a
third of cases of community-acquired pneumonia, in par-
ticular influenza viruses, rhinoviruses, and coronaviruses.
Dual viral infections are common, and a large proportion
of children have evidence of viral-bacterial co-infectionral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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logical links between viral primary infection and second-
ary bacterial super-infection and pneumonia currently
represents a major challenge for improving the prevention
and medical management of pneumonia.
Despite their importance in terms of morbidity as well
as infant mortality, microbiological aetiologies of ARIs
represent a complex, which has yet to be fully character-
ized in developed countries and remains largely unknown
in developing countries. Despite recent improvements due
to prospective studies launched during or following the
influenza A(H1N1)pdm09 in Peru and Ecuador [7,8], the
information about ILIs in the tropical Hispanic regions of
South America is scarce and the epidemiology remains in-
sufficiently characterised.
Here, we have performed the first study of ILIs in Bolivia,
which covers 3 years from January 2010 to September
2012. The viral aetiology of infections was investigated
based on naso-pharyngeal swabs collected in a National
Reference Laboratory in the city of Santa Cruz de la Sierra
and real time PCR molecular biology techniques, viral cul-
tures and phylogenetic analyses.
Results
Characteristics of the sample studied
The number of samples that could be analysed each
year at Centro Nacional de Enfermedades Tropicales,
CENETROP was determined according to logistical con-
siderations (257 in 2010, 163 in 2011 and 144 in 2012;
total = 564). We did not attempt to build a representative
sample of specimens received at CENETROP (supposedly
poorly representative of ILIs in the general population
of Santa Cruz), but rather examined a similar number
of samples in each age group to allow a comprehensive
aetiological analysis in all age classes. Our final sample has
equivalent numbers of swabs in the 0–9, 10–19, 20–29
and 30–39 age classes (90 to 98 per class) but slightly
lower numbers in the older classes (40–49: 70; 50–59:
59; ≥60: 61) due to the limited number of samples re-
ceived at CENETROP for these age groups. As expected,
it under-represents the 0–9 years old (yo) age group
(which includes ~35% of eligible samples received), and
over-represents the 30–39, 40–49, 50–59 and ≥60 yo age
groups (Additional file 1). The general characteristics and
distribution of cases are presented in Table 1. The gender
ratio (M/F) is 0.84 and the history of influenza vaccination
clearly shows that a limited proportion of the population
received influenza vaccines, in particular in the elderly
(0.53% have received at least one dose of influenza vaccine
in their life in the ≥60 yo age group).
Virological results in age groups
Of the 564 samples tested, 283 (50.2%) were positive
for at least one virus (Table 1) with influenza viruses(Flu A: ~15%; Flu B: ~9%), rhinoviruses (hRV) (~8%),
coronaviruses E229&OC43 (hCoV E229&OC43) (~5%)
and respiratory syncytial virus hRSV (~4%) being the
most frequently identified. The pattern of viral infec-
tions varied according to age groups (Figure 1A). The
elucidation rate was the highest (>60%) in samples
from patients under the age of 10 yo and the lowest
(<40%) in patients ≥60 yo (Figures 1A and B). Since
all samples originated from symptomatic patients, this
may be due either to the higher prevalence of the vi-
ruses tested or to the higher level of viral shedding in
children.
The 0–4 yo age group displayed specific epidemio-
logical characteristics with the majority of hRSV infec-
tions (infection rate: 23.19%) and a remarkably low
proportion of influenza infections: <7.5% compared
with ~38% in the 5–9 yo age group, ~26.5% in the 10–
59 yo age classes and ~16% in those ≥60 yo.
Adenoviruses were most frequently identified in chil-
dren under the age of 10, bocaviruses in patients under
the age of 20 and hCoV E229 & OC43, although
present in all age groups, were more prevalent in pa-
tients ≥40 yo. Interestingly, metapneumoviruses (hMPV)
were detected in both children and adults with the most
elevated rate of infection in the ≥60 yo age group (~5%)
and enteroviruses/parechoviruses were also found in both
children and adults. Rhinoviruses were identified in all age
groups (up to ~10% in patient over 60 years of age).
Nearly 3% of samples showed dual viral infections
(Table 1): 8 (9.4%) of the 85 influenza A viruses, 5
(11.4%) of the 44 rhinoviruses and 5 (17.8%) of the 28
hCoV E229&OC43 infections detected were diagnosed
in a situation of co-infection. Co-infections were specific-
ally frequent in the case of adenoviruses (38.9%). Despite a
high number of influenza B cases (50) no co-infection was
noted. The rate of dual infections was high for bocaviruses
and enteroviruses/parechoviruses (≥40%) and low for
metapneumoviruses and parainfluenzaviruses (<10%) but
this was based on a limited number of cases. The me-
dian age was not different in patients with single or dual
infections.
Temporal distribution of virological results
The curve of positive samples followed that of sam-
ples tested (Figure 2B) and that of samples received at
CENETROP (Figure 2A). Peaks of detection matched
peaks of reception of samples, which globally followed the
seasonal subtropical pattern of ILIs observed in Bolivia,
with one peak during the austral autumn and a second
during the austral winter season. In 2010, a great number
of samples could be studied (257) allowing to precisely fol-
low several peaks of activity corresponding to a mosaic of
viruses including Flu B, hRSV, hRV, Flu A A/H3N2 and A
(H1N1)pdm09 and hCoV E229&OC43. In 2011 and 2012,
Table 1 Characteristics of the population studied and
viral aetiologies of ILIs (January 2010 September 2012)
N % +/−CI















≥ 60 61 10.82
Influenza vaccination history 65 11.52 2. 80
Before 2010 5 0.89 0.78
After 2010 60 10.64 2.69
Age groups
0-4 5 0.89 0.78
5-9 0 0.00 0.00
10-19 6 1.06 0.85
20-29 14 2.48 1.30
30-39 17 3.01 1.43
40-49 9 1.60 1.04
50-59 11 1.95 1.15
≥ 60 3 0.53 0.60
Virus detected 283 50.18 5.85
Influenza A/H1N1p 48 8.51 2.41
Influenza A/H3N2 37 6.56 2.11
Influenza B 50 8.87 2.46
Rhinovirus 44 7.80 2.31
Coronavirus E229 & OC43 28 4.96 1.84
RSV 23 4.08 1.67
Adenovirus 18 3.19 1.47
Metapneumovirus 12 2.13 1.20
Bocavirus 9 1.60 1.04
Parainfluenzavirus 1&3 9 1.60 1.04
Enterovirus and Parechovirus 5 0.89 0.78
Total dual viral infection 16 2.84 1.39
Adenovirus - Influenza A 3 0.53 0.60
Adenovirus - Coronavirus E229 & OC43 2 0.35 0.49
Table 1 Characteristics of the population studied and
viral aetiologies of ILIs (January 2010 September 2012)
(Continued)
Bocavirus - Rhinovirus 2 0.35 0.49
Coronavirus E229 & OC43-Rhinovirus 2 0.35 0.49
Influenza A - Bocavirus 2 0.35 0.49
Influenza A - Adenovirus 1 0.18 0.35
Influenza A - Coronavirus E229 & OC43 1 0.18 0.35
Metapneumovirus - Rhinovirus 1 0.18 0.35
Enterovirus and Parechovirus - Adenovirus 1 0.18 0.35
Enterovirus and Parechovirus - Influenza A 1 0.18 0.35
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and 144, respectively), but still sufficient to elucidate the
main peaks of activity with a major incidence of Flu A
(H1N1)pdm09 in 2011 and Flu B in 2012, co-circulating
with a variety of other viruses (see Figure 2C). Epidemio-
logical peaks were generally associated with a predomin-
ant virus (Flu B in March 2010, hRV in August 2010,
Flu A/H3N2 in November 2010, Flu A(H1N1)pdm09
in October 2011 and Flu B in March 2012), but the
co-circulation of other viruses was the general rule (with
the exception of Flu A/H3N2 in November 2010) and
peaks also included 30-50% of infections by different
viruses.
This is summarised in Figure 1C that shows a clear
epidemiological evolution. In 2010, following the 2009
Flu A(H1N1)pdm09 pandemic wave, influenza A infec-
tions were for the most part due to Flu A/H3N2 and as-
sociated to a large number of Flu B and rhinovirus
infections and a variety of less prevalent viruses. By con-
trast, year 2011 was characterised by the massive come
back of Flu A(H1N1)pdm09, the low number of Flu B,
the emergence of a large number of hCoV E229&OC43
infections and the absence of hRSV infections. In 2012,
the situation changed again with a large number of Flu
B and hRSV infections and the persistence of a signifi-
cant proportion of rhinovirus and Flu A(H1N1)pdm09
infections. Altogether, this provides a striking picture of
a moving infection pattern, which is presumably mod-
elled by the herd immunity in the most epidemiologi-
cally susceptible populations. The complete disappearance
of hRSV infections in 2011 represents a specific case that
was never encountered by the authors in Europe.
Phylogenetic analyses of influenza virus A and B
sequences
Cell culture isolates of influenza A/H3N2 (N = 4), influ-
enza A(H1N1)pdm09 (N = 19) and influenza B2 (N = 11)
viruses were obtained. Eight-segment genomic sequences
were produced for Flu A/H3N2 isolates (GenBank acces-
sion numbers KF612026-KF612180) and Flu A/H3N2
Figure 1 Global distribution of viral aetiologies according to age group and year of collection. A- Viral aetiologies in age groups.
B- Distribution of positive and negative samples in age groups. C– Yearly assessment of viral diagnoses.
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Partial sequences (segments HA, NA, NS, M) were pro-
duced for Flu B isolates (GenBank accession numbers
KF612212- KF612267). The corresponding sequences
were used for further phylogenetic analyses.
Influenza B virus
Influenza B viruses are divided into two antigenic line-
ages (Victoria/87 and Yamagata/88) since 1983. Both of
them frequently co-circulate during epidemic periods [9]
and segment reassortment between strains of both line-
ages is frequent, making it difficult to produce robust
complete-genome phylogenetic analyses. Here, evolu-
tionary trees were reconstructed from the alignment of
485 HA sequences and showed that ten out of the eleven
2010 and 2012 Bolivian Flu B strains studied were in the
Victoria/87 lineage, and one (2012) in the Yamagata/88
lineage. Victoria-related Bolivian isolates appear in two
distinct clusters, together with other South American
isolates (Figure 3). The first cluster, supported by a 98%
bootstrap resampling value (Additional file 2), includes
the 2012 Bolivian isolates, together with a vast majority
of Central and South American isolates in the 2010–
2012 period and a limited number of isolates from
different origin (Asia, North America, Australia). Ac-
cording to the tree topology, the 2012 South American
cluster may originate from 2010 Australian isolates
(observed both at the root and within this cluster). The
second cluster, supported by a 100% bootstrap value
(Additional file 3), includes the 2010 Bolivian isolates,together with other Bolivian and South American iso-
lates in the same period. The third cluster (within the
Yagamata lineage), supported by a 94% bootstrap value
(Additional file 4), seems to be issued from 2007 Asian
isolates and includes one 2012 Bolivian isolate, together
with a variety of other Bolivian, Central and South
American, North American and Asian isolates in the
2007–2012 period.
Altogether, these results demonstrate the co-circulation
of viruses from different lineages in Bolivia and the exist-
ence of a global epidemiological system in which influenza
B of various origin (presumably most frequently from
Australia, Asia and North America) circulate in Central
and South America.
Influenza A/H3N2
Figure 4 presents a tree reconstructed from 2,643 HA
sequences. It illustrates the genetic drift of H3N2 viruses
since 1991, but also the limited information available re-
garding South American strains before 2008.
Sequences from H3N2 2011–2012 Bolivian isolates
appear in 3 clusters in the so-called Victoria/208
lineage. Cluster 1 (Additional file 5) includes a 2012
Bolivian isolate, together with isolates of various geo-
graphical origins. The 2012 South American isolates
group with 2011 Asian and Australian isolates and
may therefore be epidemiologicaly linked. Cluster 2
(Additional file 6) includes a 2011 Bolivian strain
together with 2011 and 2012 South American isolates.
Cluster 3 (Additional file 7) includes 2012 South
Figure 2 Temporal distribution of samples. A- The dash green curve represents nasal swabs received at CENETROP. B- The black dotted line
represents samples tested, and the red curve represents positives (at least one virus detected). C– Weekly distribution of positives for Flu A/H3N2,
Flu A(H1N1)pdm09, Flu B, rhinoviruses and coronaviruses E229 & OC43.
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(low bootstrap values).
These data suggest that variants belonging to distinct
evolutionary clusters have circulated simultaneously in
South America during the 2011 and 2012 influenza sea-
sons. This information is relevant for optimising the for-
mula of the seasonal influenza vaccine in order to
provide efficient protection [10].Influenza A(H1N1)pdm09
Figure 5 presents a tree reconstructed from 3,412
complete genomic influenza A(H1N1)pdm09 sequences
in the 2009–2013 period. Bolivian isolates appear in 3
distinct clusters.Cluster 1 (Additional file 8) includes 2011 and 2012
Bolivian isolates. The 2011 Bolivian isolates were col-
lected from October to December and are related to
German strains collected in February 2011, suggesting
the circulation in Bolivia during the 2011 (South hemi-
sphere) influenza season of viruses derived from those
that circulated in Europe at the end of the previous
(North hemisphere) influenza season. The presence in
the same cluster (100% bootstrap support) of Bolivian
strains that circulated during the first 2012 influenza
epidemic peak (March 2012, Figure 2) indicates that the
virus has been continuously circulating at low level after
November 2011 and reveals the possible persistent viral
circulation over long periods (possibly a one-year period –





































Figure 3 Phylogenetic analysis of Haemagglutinin (HA) coding sequence of 485 influenza B viruses. Main bootstrap values are indicated
at forks. The Victoria/87 and Yamagata/88 lineages are indicated in pink and green, respectively. The tree includes 474 complete coding
sequences from GenBank and 11 complete coding sequences from this study, GenBank accession numbers KF612026-KF612180. Clusters 1, 2 and
3 are detailed in Supplementary files (Additional file 2, Additional file 3 and Additional file 4 respectively).
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South American strains for which only HA sequences
are available (data not shown).
Clusters 2 and 3 are poorly informative (Additional file 9
and Additional file 10, low bootstrap supports). Cluster 2
includes 2009 and 2010 Bolivian isolates together with 2009
South American, Asian and North American isolates and
cluster 3 includes 2009 Bolivian isolates together with 2009
South American, North American and European isolates.
In addition, a complete genomic sequence available for a
2009 isolate made in La Paz, Bolivia (strain A/La Paz/
WR0096T/2009) is located in a different cluster of the
evolutionary tree (see Figure 5).
Altogether, the main information arising is that several
evolutionary lineages co-circulated in Bolivia during the
2009 H1N1 pandemic wave.
Discussion
This study represents the first attempt to characterise
the viral aetiology of ILIs in Bolivia and the first in South
America in the post-influenza A(H1N1)pdm09 period. It
was not designed for providing a representative picture
of the general Bolivian population: (i) samples originatedfrom the region of Santa Cruz only (this item is further
discusses below); (ii) samples sent to CENETROP were
not expected to faithfully represent ILIs in the region of
Santa Cruz, with obvious recruitment biases such as clin-
ical severity or access to public medical care; (iii) sampling
was performed with the objective of obtaining equivalent
numbers of cases in all age classes.
The information obtained should therefore be analysed
with precautions. Firstly, the great year-to-year variation
of infection epidemiological patterns is a reminder that
the epidemiology of ILIs should be studied over long pe-
riods of time. Each of the three years studied here would
have provided, if analysed separately, a partial view of
the situation and would have lead to erroneous conclu-
sions (e.g., the absence of hRSV infections in Bolivian
children extrapolated from 2011 data). The analysis of a
3-year period is expected to smooth such epidemio-
logical jolts but an extended observation period would
have undoubtedly revealed more information about the
viruses that circulated at low rates in the period stud-
ied (e.g., parechoviruses, parainfluenzaviruses). Secondly,
Bolivia includes territories with diverse geographical, cli-
matic and ecological characteristics. Santa Cruz is located
Figure 4 Phylogenetic analysis of Haemagglutinin (HA) of 2,643 influenza A/H3N2 viruses. The tree includes 2,639 complete coding
sequences from GenBank and 4 complete coding sequences from this study, GenBank accession numbers KF612181-KF612211. Clusters 1, 2 and
3 are detailed in Supplementary files (Additional file 5, Additional file 6 and Additional file 7 respectively).
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mate whilst La Paz is in a western Andean high-altitude
area with a colder and dryer climate [11]. This may ex-
plain important epidemiological differences observed be-
tween both cities, as exemplified by the case of influenza
A(H1N1)pdm09: in 2010, we observed a very limitednumber of Flu A(H1N1)pdm09 infections in Santa Cruz
whilst the PAHO surveillance system reported an intense
circulation of the virus in La Paz during the first months
of the year (PAHO surveillance website: http://ais.paho.
org/phip/viz/ed_flu.asp); in 2011, a large outbreak occurred
in Santa Cruz (see Figures 1 and 2), whilst only a few cases
Figure 5 Phylogenetic analysis of complete coding sequences of 3,412 influenza A(H1N1)pdm09 viruses. The tree includes 3,393
complete coding sequences from GenBank and 19 complete coding sequences from this study, GenBank accession numbers KF612212- KF612267. (*):
strain A/La Paz/WR0096T/2009. Clusters 1, 2 and 3 are detailed in Additional files (Additional file 8, Additional file 9 and Additional file 10 respectively).
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was observed in La Paz, but not in Santa Cruz. This clearly
indicates that epidemiological data collected in Santa Cruz
cannot be extrapolated easily to the Andean regions of
Bolivia. Divergent influenza epidemiological patterns ac-
cording to geographical distribution were finely docu-
mented in a previous Peruvian study [7].
Despite the fact that the local epidemiology of ARIs is
modelled by herd immunity and environmental factors,
the global picture of ARIs that arises from our study
conforms with that observed in different regions of the
world. In particular, the choice of the pathogens tested
seems to be relevant since (i) the rate of elucidation is
close to what is observed in France, using the same mo-
lecular assays (authors’ personal data), (ii) peaks of de-
tection match the ILI epidemiological peaks and (iii) in
previous studies performed in Brazil, the different viruses
identified in the current study were detected, confirming
their circulation in the region [12-16]. The distribution of
cases in age groups is also essentially similar with whatwas reported elsewhere, e.g., in Ecuador [8]. The most sur-
prising items, which deserve investigations on an extended
period of time, were the unusually low frequency of influ-
enza infections in the 0–4 yo age group and the complete
RSV eclipse in 2011. However, precise comparison with
data collected in South America is most often difficult,
e.g., with a molecular study in Ecuador [8] and a previous
large study in Peru [7] (different periods investigated,
viruses detected using immunofluorescence tests, par-
echoviruses, coronaviruses, metapneumoviruses and
rhinoviruses not tested).
The genetic characterisation of influenza strains indi-
cates that viruses belonging to distinct evolutionary line-
ages of Flu A(H1N1)pdm09, Flu A/H3N2 and Flu B have
co-circulated in Bolivia. Interestingly, an increasing num-
ber of influenza sequences has been made available since
2008 and phylogenetic reconstructions revealed, on the
one hand, the existence of South American evolutionary
clusters of influenza strains, and on the other hand a com-
plex epidemiological relationship with the rest of the
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the study period of viruses originating from Central and
North America, Europe, Asia and Australia.Conclusion
This study provided the first systematic and broad-
spectrum information regarding the viral aetiology of
ILIs in Bolivia. A continued effort is needed to accurately
characterise the epidemiology of ILIs in the different re-
gions of the country to guide vaccination campaigns for
at-risk populations and improve the medical manage-
ment of patients. In accordance with previous investiga-
tions performed in Peru [7], our results emphasise the
requirement for a reinforced genetic follow-up of influ-
enza strains circulating in South America to further in-
form the preparation of vaccines used in the region.
Methods
Case definition, population and samples
The recruitment of cases was operated following the
broad spectrum WHO case definition of ILIs: anybody
with fever of 37.8°C or higher, associated with one respira-
tory symptom was identified as ILI infection and eligible
for investigation. We used naso-pharyngeal swabs sam-
pled in hospitals and health centres in the region of Santa
Cruz and sent to the CENETROP (Centro Nacional de
Enfermedades Tropicales, Santa Cruz, Bolivia) for diagno-
sis from January 2010 to September 2012. All specimens
had been sampled between day 0 and day 4 following clin-
ical onset, sent to the laboratory at room temperature
using a universal transport media and kept at −20°C upon
reception. All patients or their legal representative gave
oral consent for the shipment of samples to CENETROP
and the detection of respiratory pathogens. To provide a
preliminary report of viral aetiologies in all age groups
(i.e., information that may be translated easily for Public
health purposes), a random selection of an equivalent num-
ber of samples was operated in age groups (0–9, 10–19,
20–29, 30–39, 40–49, 50–59 and ≥60 years of age) for each
year of the study.Virus identification
Aetiological identification was performed using TaqMan
probe-based real-time PCR and RT-PCR protocols. Sam-
ples were spiked by MS2 and T4 phages, used as internal
controls [17]. RNA and DNA were co-extracted from
200 μL of each sample and eluted in a 90 μL final vol-
ume (QIAcube automate and QIAamp MinElute Virus
Spin Kit, both from Qiagen). Random hexaprimer re-
verse transcription of RNA genomes was performed
using the TaqMan Transcriptase reverse reagent kit
(Roche). Amplifications were performed in a final volume
of 25 μL, using 3 μL of nucleic acid solution, the FastqPCR MasterMix with no Rox (Eurogentec) and a
Bio-Rad CFX96 Touch™ Real-Time PCR Detection System.
Amplification protocols included the specific detection
of seasonal Influenza A viruses (Flu A, [18]), pandemic
A/H1N1(2009) influenza virus (Flu A(H1N1)pdm09,
([19])), Influenza B virus (Flu B, [18]), Parainfluenzaviruses
1&3 (hPIV 1&3, [20]), Respiratory syncytial viruses A and
B (hRSV A, hRSV B, [21]), Coronaviruses E229&OC43
(hCoV E229&OC43, [22]), Rhinovirus (hRV, [23], Adeno-
viruses (hAdV, [24]), Enteroviruses & Parechoviruses
(hEVs, hPeV, [25]), human metapneumoviruses A and B
(hMPV, [26]), human Bocaviruses (hBoV, [27]).Culture
Samples providing a strong positive real-time PCR result
(Ct < 30) for influenza A or B viruses were used for virus
isolation using MDCK cells and a standard isolation
protocol (Additional file 11).
In addition to strains isolated in the course of the
current study, 6 influenza A(H1N1)pdm09 virus strains
isolated at CENETROP in the June-August 2009 period
were sequenced to reinforce phylogenetic analyses (see
below).Sequencing
200 μL of clarified supernatant from Influenza A or B
positive cell cultures were extracted using the EZ1® Qia-
gen instrument and the EZ1® Virus Mini Kit v2.0 with-
out RNA Carrier (Qiagen). All 8 segments of influenza
A virus were amplified in a single reaction using the
SuperScript® III One-Step RT-PCR System with the Plat-
inum® Taq High Fidelity Kit and the universal primers
univ12 and univ13 [28].
To obtain influenza B virus sequences, we used a simi-
lar protocol and one set of primers (BM-NS-1 and BM-
NS-2) to amplify the HA, NA and NS segments [29] and
another set of newly designed primers (M-2eFor: AG
AAGYASAGCATTTTCTTGTGA and M-2eRev: TAAA
CACCCACATYCCAAACGT) to amplify the M segment.
PCR products were purified (Nucleofast PCR plate,
Machrey Nagel) and sequenced using the NGS Ion
Torrent technology: briefly, DNA concentrations were
adjusted to 200nM (Qubit® dsDNA BR Assay Kit and
Qubit® 2.0 Fluorometer) and a library of barcoded
100–200 nt fragments was built using the Diagenode
Bioruptor UCD-200, the Xpress™ Barcode Adapters kit
and the AB Library Builder™ (Life Technologies). Clonal
amplification was performed using the Ion PGM™ Tem-
plate OT2 200 Kit and the Ion OneTouch™ 2 Instrument
(both from Life Technologies). Final sequencing was per-
formed using the Personal Genome Machine® (PGM™)
System, the Ion PGM™ Sequencing 200 Kit v2 and the Ion
316™ Chip Kit (Life Technologies).
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To produce consensus sequences for each isolated strains,
reads obtained from using the Ion Torrent protocol were
processed using the CLC Genomics Workbench software
6.04 (CLCbio, Aarhu, Denmark) and a home developed
program and then mapped onto concatenated reference
sequences.
In the case of A/H1N1(2009) phylogenies, concatenated
coding sequences of the eight segments from the
complete genomic sequences produced as reported above
from Bolivian strains were aligned with complete genomic
sequences retrieved from databases (total: 3,412 genomic
sequences). In the case of A/H3N2 and influenza B phy-
logenies we collected complete genomic sequences from
databases but used only the HA gene sequences to pro-
duce alignments (A/H3N2: 2,643 sequences; influenza B:
485 sequences). Alignments were conducted using the
MUSCLE programme [30], implemented in the Influenza
Research Database (Multiple Sequence Alignment: http://
www.fludb.org/brc/) and subsequently used to perform
phylogenetic analyses using the MEGA 5.05 programme
[31], the Jukes Cantor algorithm for distance calculation
and the Neighbour joining method for tree building.Additional files
Additional file 1: Distribution of the eligible and studied
populations in age groups.
Additional file 2: Influenza B phylogeny cluster 1. This is a
magnification of Influenza B phylogeny cluster 1 (Figure 3). Legend shape
represents the year of strain isolation: square for 2012; circle for 2011;
triangle with the tip up for 2010, triangle with the tip down for 2009;
rhombus for <2009. The colour represents the geographical origin: light
blue for Bolivian strains from this study; pink for Bolivian strains from
databases; dark blue for South American strains from databases.
Additional file 3: Influenza B phylogeny cluster 2. This is a
magnification of Influenza B phylogeny cluster 2 (Figure 3). Legend shape
represents the year of strain isolation: square for 2012; circle for 2011;
triangle with the tip up for 2010, triangle with the tip down for 2009;
rhombus for <2009. The colour represents the geographical origin: light
blue for Bolivian strains from this study; pink for Bolivian strains from
databases; dark blue for South American strains from databases.
Additional file 4: Influenza B phylogeny cluster 3. This is a
magnification of Influenza B phylogeny cluster 3 (Figure 3). Legend shape
represents the year of strain isolation: square for 2012; circle for 2011;
triangle with the tip up for 2010, triangle with the tip down for 2009;
rhombus for <2009. The colour represents the geographical origin: light
blue for Bolivian strains from this study; pink for Bolivian strains from
databases; dark blue for South American strains from databases.
Additional file 5: Influenza A/H3N2 cluster 1. This is a magnification
of Influenza A/H3N2 phylogeny cluster 1 (Figure 4). Legend shape
represents the year of strain isolation: square for 2012; circle for 2011;
triangle with the tip up for 2010, triangle with the tip down for 2009;
rhombus for <2009. The colour represents the geographical origin: light
blue for Bolivian strains from this study; pink for Bolivian strains from
databases; dark blue for South American strains from databases.
Additional file 6: Influenza A/H3N2 cluster 2. This is a magnification
of Influenza A/H3N2 phylogeny cluster 2 (Figure 4). Legend shape
represents the year of strain isolation: square for 2012; circle for 2011;
triangle with the tip up for 2010, triangle with the tip down for 2009;rhombus for <2009. The colour represents the geographical origin: light
blue for Bolivian strains from this study; pink for Bolivian strains from
databases; dark blue for South American strains from databases.
Additional file 7: Influenza A/H3N2 cluster 3. This is a magnification
of Influenza A/H3N2 phylogeny cluster 3 (Figure 4). Legend shape
represents the year of strain isolation: square for 2012; circle for 2011;
triangle with the tip up for 2010, triangle with the tip down for 2009;
rhombus for <2009. The colour represents the geographical origin: light
blue for Bolivian strains from this study; pink for Bolivian strains from
databases; dark blue for South American strains from databases.
Additional file 8: Influenza A(H1N1)pdm09 cluster 1. This is a
magnification of Influenza A(H1N1)pdm09 phylogeny cluster 1 (Figure 5).
Legend shape represents the year of strain isolation: square for 2012;
circle for 2011; triangle with the tip up for 2010, triangle with the
tip down for 2009; rhombus for <2009. The colour represents the
geographical origin: light blue for Bolivian strains from this study; pink for
Bolivian strains from databases; dark blue for South American strains from
databases.
Additional file 9: Influenza A/H1N1 cluster 2. This is a magnification
of Influenza A(H1N1)pdm09 phylogeny cluster 2 (Figure 5). Legend shape
represents the year of strain isolation: square for 2012; circle for 2011;
triangle with the tip up for 2010, triangle with the tip down for 2009;
rhombus for <2009. The colour represents the geographical origin: light
blue for Bolivian strains from this study; pink for Bolivian strains from
databases; dark blue for South American strains from databases.
Additional file 10: Influenza A/H1N1 phylogeny cluster 3. This is a
magnification of Influenza A(H1N1)pdm09 phylogeny cluster 3 (Figure 5).
Legend shape represents the year of strain isolation: square for 2012;
circle for 2011; triangle with the tip up for 2010, triangle with the
tip down for 2009; rhombus for <2009. The colour represents the
geographical origin: light blue for Bolivian strains from this study; pink for
Bolivian strains from databases; dark blue for South American strains from
databases.
Additional file 11: Sequenced sample information.
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